Medical Device | September 24, 2025
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
RN3161 is engineered to reduce fat while preserving lean mass, setting it apart from current treatment options
The HCl gas is generated continuously which is absorbed in the water scrubber using a chilled falling film system
Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
Breakthrough UNITY 4D Phaco delivers up to 2X faster nucleus removal and 41% less energy into the eye
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Earlier in July 2025, Dazublys has received the marketing authorisation in the European Union from the European Commission
The facility will be positioned as a Centre of Excellence for tertiary care services
Subscribe To Our Newsletter & Stay Updated
